Improving blood pressure care in childhood lupus
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy, Kidney & urinary clinical trials.
This study is working with doctors' offices to improve how blood pressure is managed in children with lupus. By taking part, you'll help find better ways to care for young people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child have a diagnosis of childhood-onset lupus (SLE).
- You or your child have seen a pediatric rheumatology doctor in the last 12 months.
- If you are the patient, you are at least 12 years old.
- If you are a caregiver or staff member, you must be 18 or older.
- For interviews, you need access to a device with audio or video calling.
- You must be able to give your verbal agreement to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry for people with lupus and their families. It helps researchers learn more about lupus and improve care. You or your child can join if you have a lupus diagnosis.
This study tests whether helping lupus patients and their doctors communicate better leads to taking medications more consistently. Participants will have their doctor visits recorded and use a phone app to track their medicines.
This study tests a program to help teenagers and young adults with childhood-onset lupus manage symptoms like fatigue, sadness, or pain. It aims to improve daily life and well-being.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This trial collects health data from people recently diagnosed with lupus to improve treatment and care. It is a registry study, not a drug-testing trial, and aims to understand how patients fare over time.
This registry tracks the safety and effectiveness of lupus treatments over time. If you have SLE and are starting a new treatment or were recently diagnosed, joining helps doctors learn which medicines work best.
Hear when a new Systemic Lupus Erthematosus (SLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.